Michelle Long is a Gastroenterology physician affiliated with Boston University. OpenAlex indexes 212 publications with 8,365 citations (h-index 42).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
830 Harrison Avenue
Evans - Gastroenterology
Boston, MA 02118
Telephone
617-638-6525Provider last certified this registry record 3 May 2021.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20228 payments$17,933openpaymentsdata.cms.gov ↗
- Novo Nordisk IncProgram year20213 payments$11,976openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2018–2022 per NIH RePORTER. The latest:
- Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community
Boston Medical Center
FY2022$188,447K23DK113252 - Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community
Boston Medical Center
FY2021$188,447K23DK113252 - Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community
Boston Medical Center
FY2020$190,885K23DK113252
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
New England Journal of Medicine
2025 - A global research priority agenda to advance public health responses to fatty liver disease
Journal of Hepatology
2023 - An international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease
HepatoBiliary Surgery and Nutrition
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Holick, MD
Boston University
Gene Kwan, MD
Boston University
Joseph Antin, MD
Boston University
George O'Connor, MD
Boston University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”